Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-MBIP (1-344) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
MBIP |
Gene ID: |
51562 |
Uniprot ID: |
MBIP1_HUMAN |
Immunogen Region: |
1-344 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-344 of human MBIP (NP_057670.2). |
Immunogen Sequence: |
MAAATELNRPSSGDRNLERR CRPNLSREVLYEIFRSLHTL VGQLDLRDDVVKITIDWNKL QSLSAFQPALLFSALEQHIL YLQPFLAKLQSPIKEENTTA VEEIGRTEMGNKNEVNDKFS IGDLQEEEKHKESDLRDVKK TQIHFDPEVVQIKAGKAEID RRISAFIERKQAEINENNVR EFCNVIDCNQENSCARTDAI FTPYPGFKSHVKVSRVVNTY GPQTRPEGIPGSGHKPNSM |
Tissue Specificity | Ubiquitous. High expression seen in the heart and lung. |
Function | Inhibits the MAP3K12 activity to induce the activation of the JNK/SAPK pathway. Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. |
Protein Name | Map3k12-Binding Inhibitory Protein 1Mapk Upstream Kinase-Binding Inhibitory ProteinMuk-Binding Inhibitory Protein |
Database Links | Reactome: R-HSA-3214847Reactome: R-HSA-9772755 |
Cellular Localisation | NucleusCytoplasmShows A Cytoplasmic Localization When Coexpressed With Map3k12 |
Alternative Antibody Names | Anti-Map3k12-Binding Inhibitory Protein 1 antibodyAnti-Mapk Upstream Kinase-Binding Inhibitory Protein antibodyAnti-Muk-Binding Inhibitory Protein antibodyAnti-MBIP antibodyAnti-BM-015 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance